We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
806 result(s) found, displaying 71 to 80
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR SITAGLIPTIN/METFORMIN 50/1000 sitagliptin (as hydrochloride monohydrate) 50 mg / metformin HCl 1000 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR SITAGLIPTIN/METFORMIN 50/500 sitagliptin (as hydrochloride monohydrate) 50 mg / metformin HCl 500 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SITAGLO-MET 50/1000 sitagliptin (as hydrochloride monohydrate) 50 mg / metformin hydrochloride 1000 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR SITAGLIPTIN/METFORMIN 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg / metformin HCl 850 mg film-coated tablet blister pack.
-
Cancellation by sponsorRequested by Pharmacor Pty Ltd
-
Cancellation by sponsorRequested by Pharmacor Pty Ltd
-
Prescription medicine registrationActive ingredients: nebivolol hydrochloride.
-
Prescription medicine registrationActive ingredients: enoxaparin sodium.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025